Diane Graham alleged she suffered silicone leakage, placing her at risk for cancer and other diseases.
Mentor argued federal medical device law preempted Graham’s claims because she was in a clinical study approved by the Food and Drug Administration when she received the Mentor silicone-gel implants in 2000.
Unresolved fact questions regarding the status of the Mentor implants at issue, and whether Graham was part of a study, make dismissal inappropriate, the U.S. District Court for the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.